<code id='4000318F1F'></code><style id='4000318F1F'></style>
    • <acronym id='4000318F1F'></acronym>
      <center id='4000318F1F'><center id='4000318F1F'><tfoot id='4000318F1F'></tfoot></center><abbr id='4000318F1F'><dir id='4000318F1F'><tfoot id='4000318F1F'></tfoot><noframes id='4000318F1F'>

    • <optgroup id='4000318F1F'><strike id='4000318F1F'><sup id='4000318F1F'></sup></strike><code id='4000318F1F'></code></optgroup>
        1. <b id='4000318F1F'><label id='4000318F1F'><select id='4000318F1F'><dt id='4000318F1F'><span id='4000318F1F'></span></dt></select></label></b><u id='4000318F1F'></u>
          <i id='4000318F1F'><strike id='4000318F1F'><tt id='4000318F1F'><pre id='4000318F1F'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:541
          photo of a person's brown eye -- health coverage from STAT
          Adobe

          In the clinical trial, the gene therapy seemed to be helping the boy’s skin wounds heal. But, his doctors wondered, could it also help his eyes?

          The boy, Antonio Vento Carvajal, had a genetic condition called epidermolysis bullosa, or EB, which causes the skin to be so fragile that even the slightest friction can cause blisters or tears. Antonio, like some patients, also had eye issues as a result of the disease.

          advertisement

          His eyelids were fusing to the eyes themselves. The eyes’ white tissue was growing over his corneas. The problems caused his vision to deteriorate to the point that, in his right eye, he could detect nothing more than the motion of someone waving a hand in front of his face.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          Will generative AI in health care meet the fate of IBM's Dr. Watson?
          Will generative AI in health care meet the fate of IBM's Dr. Watson?

          MikeReddyforSTATThehealthcaresectorisanotoriouslaggardwhenitcomestotechnology.Itwasslowtousecomputer

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          FDA approves first treatment for ultra

          AdobeU.S.regulatorsonWednesdayapprovedthefirsttreatmentforanultra-rarediseasethatcausespeopletogrowb